Richard A. Rawson, PhD, Research Professor, Vermont Center for Behavior and Health, Professor Emeritus, UCLA Department of Psychiatry and Biobehavioral Sciences

This activity is designed to meet the needs of primary care physicians, specialty care physicians, allied professional staff and program administrators.

Methamphetamine use has grown increasingly prevalent over the past couple decades, and fentanyl-contaminated methamphetamine has led to a significant increase in overdose deaths. Though no FDA-approved medications exist yet to treat methamphetamine use disorder, new research has demonstrated efficacy of various behavioral treatments, particularly contingency management. This webinar will provide an overview of the current state of methamphetamine use, considerations for concurrent opioid use, and strategies and interventions for treating and engaging individuals with stimulant use disorder.

At the conclusion of this activity, learners should be able to:

• Examine trends in and impacts of methamphetamine use, including concurrent use with opioids
• Identify clinical challenges and strategies for treating individuals who use stimulants
• Examine the evidence for medications and treatment interventions for stimulant use